Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities    
Net loss $ (814,334) $ (784,738)
Adjustments to reconcile net loss to net cash used in operating activities:    
Non-cash LNG inventory write-downs 0 17,826
Depreciation and amortization expense 106,082 59,561
Share-based compensation 85,128 92,627
Amortization of debt issuance costs and discount 38,826 28,552
Loss on early extinguishment of debt 82,537 96,273
Total losses on derivatives, net 269,399 208,769
Net cash used for settlement of derivative instruments (34,567) (94,170)
Impairment expense 10,095 572
Other 9,803 834
Changes in restricted cash for certain operating activities 119,831 92,589
Changes in operating assets and liabilities:    
Accounts and other receivables (128,042) (2,226)
Inventory (28,051) (25,966)
Accounts payable and accrued liabilities 39,599 16,671
Deferred revenue (2,960) (3,003)
Other, net 47,627 21,252
Net cash used in operating activities (199,027) (274,577)
Cash flows from investing activities    
Property, plant and equipment, net (3,449,161) (5,747,596)
Use of restricted cash for the acquisition of property, plant and equipment 3,488,263 5,330,526
Other (51,308) (111,518)
Net cash used in investing activities (12,206) (528,588)
Cash flows from financing activities    
Proceeds from issuances of debt 8,308,306 6,178,000
Repayments of debt (4,180,660) 0
Debt issuance and deferred financing costs (116,715) (519,699)
Investment in restricted cash (3,931,648) (5,161,701)
Distributions and dividends to non-controlling interest (60,159) (60,154)
Proceeds from exercise of stock options 50 2,279
Payments related to tax withholdings for share-based compensation (18,604) (44,305)
Other (317) 1,424
Net cash provided by financing activities 253 395,844
Net decrease in cash and cash equivalents (210,980) (407,321)
Cash and cash equivalents—beginning of period 1,201,112 1,747,583
Cash and cash equivalents—end of period $ 990,132 $ 1,340,262